14-3-3 eta Protein by ELISA, Serum
Ordering Recommendation
Use as an adjunct marker in the diagnosis of rheumatoid arthritis (RA). Can be used in conjunction with rheumatoid factor (RF) and anticyclic citrullinated peptide (CCP) to enhance sensitivity. 14-3-3 eta is also used to stratify disease activity and monitor treatment effectiveness.
New York DOH Approval Status
Specimen Required
Serum separator tube or red top tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP standard transport tube. (Min: 0.25 mL)
Refrigerated.
Nonserum, contaminated, heat-inactivated, severely hemolyzed, severely lipemic, or severely icteric specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month (avoid repeated freeze/thaw cycles)
Methodology
Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)
Performed
Tue
Reported
1-8 days
Reference Interval
Test Number |
Components |
Reference Interval |
---|---|---|
14-3-3 eta Protein, Serum | 0.19 ng/mL or less |
Interpretive Data
The combination of serum 14-3-3 eta with rheumatoid factor (RF) and anticyclic citrullinated peptide (anti-CCP) may enhance sensitivity and demonstrates high specificity for rheumatoid arthritis (RA) diagnosis. Elevated serum 14-3-3 eta levels may be observed in both early and established RA patients, including those who are seronegative for both RF and anti-CCP antibodies. Elevated serum 14-3-3 eta concentrations are predictive of unfavorable clinical and radiological outcomes at diagnosis and posttreatment initiation. Negative or decreased levels of 14-3-3 eta from baseline correlate with diminished radiological progression and suboptimal treatment response.
Analyte Specific Reagent (ASR)
Note
Hotline History
Hotline History
CPT Codes
83520
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3017892 | 14-3-3 eta Protein, Serum | 75880-5 |
Aliases
- 14-3-3 eta
- 14.3.3 eta
- Early RA
- joint erosion
- Juvenile Idiopathic Arthritis
- Psoriatic Arthritis
- RA
- Radiological outcomes
- Rheumatoid Arthritis